Galectin-7 Expression Potentiates HER-2-Positive Phenotype in Breast Cancer

PLoS ONE - United States
doi 10.1371/journal.pone.0166731
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Low Expression of Galectin-3 Is Associated With Poor Survival in Node-Positive Breast Cancers and Mesenchymal Phenotype in Breast Cancer Stem Cells

Breast Cancer Research
Cancer ResearchOncology
2016English

Reduction in HER-2 Protein Expression in a Breast Tumor HER-2 Positive After Only One Injection of Trastuzumab: A Case Report

Cases Journal
2009English

Trastuzumab in Combination With Metronomic Cyclophosphamide and Methotrexate in Patients With HER-2 Positive Metastatic Breast Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2006English

Aloe-Emodin Inhibits HER-2 Expression Through the Downregulation of Y-Box Binding Protein-1 in HER-2-overexpressing Human Breast Cancer Cells

Oncotarget
Oncology
2016English

Comparison of the Efficacy and Survival Analysis of Neoadjuvant Chemotherapy for Her-2-Positive Breast Cancer

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2018English

Serum HER-2 Concentration in Patients With Primary Breast Cancer

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2006English

HER-2/neu Transcriptionally Activates Jab1 Expression via the AKT/ -Catenin Pathway in Breast Cancer Cells

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2007English

Target HER Four in Breast Cancer?

Oncotarget
Oncology
2019English

Hormone Receptors, Her-2/Neu and Chromosomal Aberrations in Breast Cancer

Medical Journal Armed Forces India
Medicine
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy